⏳ Fetching live dividend data...
Home › Calculator › ESALY Dividend Calculator 2026
Eisai Co., Ltd. · OTC
Price: $61.51 · Annual div: $1.20/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in ESALY → $313.2K in 10 years · $33.80/month
Headquartered in Tokyo, Japan, Eisai Co., Ltd. is a pharmaceutical company that develops and markets a diverse range of medicinal products within Japan. Its extensive product lineup includes treatments for neurological conditions, such as Aricept for Alzheimer's disease and Lewy body dementia, Methycobal for peripheral neuropathy, and Fycompa, an antiepileptic drug for specific partial-onset and generalized tonic-clonic seizures. Eisai also offers Dayvigo, an anti-insomnia agent for adults. In the field of oncology, the company provides Lenvima, a molecularly targeted anticancer agent for thyroid cancer, renal cell carcinoma (in combination with everolimus), and hepatocellular carcinoma, alongside Halaven, a microtubule dynamics inhibitor used for breast cancer and liposarcoma. Other key pharmaceuticals include Lyrica for pain management, and Pariet, a proton-pump inhibitor effective against gastric and duodenal ulcers, reflux esophagitis, and Helicobacter pylori infections. The portfolio also features Humira, a fully human anti-TNF-alpha monoclonal antibody for autoimmune diseases like rheumatoid arthritis. Beyond prescription drugs, Eisai markets consumer health items such as Chocola BB Plus, a vitamin B2 preparation for rough skin and stomatitis, as well as various third-class over-the-counter drugs, designated quasi-drugs, and food products with nutrient function. Originally founded in 1941 as Nihon Eisai Co., Ltd., the company adopted its current name, Eisai Co., Ltd., in 1955.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open ESALY position with:
Real after-tax yield depends on where you live and how you hold ESALY.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 1.95% | -0.85% | $195 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 1.66% | -1.14% | $166 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 1.56% | -1.24% | $156 / yr |
| 🇬🇧 UK ISA | 0% | 1.95% | -0.85% | $195 / yr |
| 🇬🇧 UK Taxable | 8.75% | 1.78% | -1.02% | $178 / yr |
| 🇨🇦 TFSA | 0% | 1.95% | -0.85% | $195 / yr |
| 🇨🇦 CA Taxable | 25% | 1.46% | -1.34% | $146 / yr |
| 🇦🇺 Super (pension) | 15% | 1.66% | -1.14% | $166 / yr |
| 🇦🇺 AU Taxable | 30% | 1.36% | -1.43% | $137 / yr |
| 🇩🇪 DE Taxable | 26.375% | 1.44% | -1.36% | $144 / yr |
| 🇫🇷 FR Taxable | 30% | 1.36% | -1.43% | $137 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $1.20/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
ESALY pays quarterly — 4 times per year. Next ex-div: TBD.
How ESALY compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for ESALY sourced from FMP /financial-growth endpoint — real data, not estimates.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the ESALY dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Eisai Co., Ltd. (ESALY) is currently trading at $61.51, 14% below its 52-week high. The current dividend yield is 1.95% based on an annual payout of $1.20 per share.
Eisai Co., Ltd. (ESALY) is a healthcare stock currently trading at $61.51 with a dividend yield of 1.95%. The company pays an annual dividend of $1.20 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings. Over the past 5 years, ESALY has grown its dividend at a compound annual rate of 7.0%.
Auto-generated from live market data. For educational purposes only — not financial advice.
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.
⏱️ Takes 30 seconds · No signup · Free forever